AZ And Ipsen Outline Brexit Contingency Plans
With the UK no nearer to deciding how hard or soft its exit from the EU will be on March 29, AstraZeneca and Ipsen have given updates on their efforts to cope with the chaos that could ensue on the medicines supply front.
You may also be interested in...
As the UK parliament prepares for next week’s vote on the Brexit deal, the government is continuing with its contingency planning for a no-deal scenario, including the acquisition of refrigerated storage for stockpiled medicines.
The UK government has issued guidance on actions the public health and care system in England should take to prepare for and cope with a potential “no deal” exit by the UK from the EU at the end of March next year. The government is also very clear on what it does not want providers such as hospitals and community pharmacies to do – stockpile medicines.
Ipsen's David Meek tells Scrip a Hard Brexit looks likely and that he's preparing the French pharma for that scenario.